对临床稳定的发热性中性粒细胞减少症和实体瘤患者进行预后评估时的常见误解。 - Suppr

Suppr

超能文献

Common misconceptions in the prognostic evaluation of clinically stable patients with febrile neutropenia and solid tumors.

作者信息

Carmona-Bayonas A, Jiménez-Fonseca P

机构信息

Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, Murcia, Spain.

Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.

出版信息

Clin Transl Oncol. 2019 Aug;21(8):1112-1114. doi: 10.1007/s12094-018-02020-8. Epub 2019 Jan 3.

DOI:10.1007/s12094-018-02020-8

PMID:30607791

Abstract

摘要

相似文献

Common misconceptions in the prognostic evaluation of clinically stable patients with febrile neutropenia and solid tumors.对临床稳定的发热性中性粒细胞减少症和实体瘤患者进行预后评估时的常见误解。

Clin Transl Oncol. 2019 Aug;21(8):1112-1114. doi: 10.1007/s12094-018-02020-8. Epub 2019 Jan 3.

SEOM clinical practice guideline: management and prevention of febrile neutropenia in adults with solid tumors (2018).SEOM 临床实践指南：实体瘤成人发热性中性粒细胞减少症的管理和预防（2018 年）。

Clin Transl Oncol. 2019 Jan;21(1):75-86. doi: 10.1007/s12094-018-1983-4. Epub 2018 Nov 23.

Accuracy of the Multinational Association of Supportive Care in Cancer (MASCC) and Clinical Index of Stable Febrile Neutropenia (CISNE) scores for predicting serious complications in adult patients with febrile neutropenia: A systematic review and meta-analysis.多国支持性护理癌症协会 (MASCC) 和中性粒细胞减少性发热临床指数 (CISNE) 评分预测成人发热性中性粒细胞减少症患者严重并发症的准确性：系统评价和荟萃分析。

Crit Rev Oncol Hematol. 2020 May;149:102922. doi: 10.1016/j.critrevonc.2020.102922. Epub 2020 Mar 3.

Calculated decisions: MASCC Risk Index for febrile neutropenia.审慎决策：发热性中性粒细胞减少症的MASCC风险指数

Emerg Med Pract. 2018 Jan 2;20(Suppl 1):3-4.

[Infections associated with hematologic diseases].

Rinsho Ketsueki. 2014 Oct;55(10):2208-20.

Application of the MASCC and CISNE Risk-Stratification Scores to Identify Low-Risk Febrile Neutropenic Patients in the Emergency Department.应用MASCC和CISNE风险分层评分识别急诊科低风险发热性中性粒细胞减少患者。

Ann Emerg Med. 2017 Jun;69(6):755-764. doi: 10.1016/j.annemergmed.2016.11.007. Epub 2016 Dec 29.

Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the Clinical Index of Stable Febrile Neutropenia in a prospective cohort of patients from the FINITE study.疑似稳定发热性中性粒细胞减少症患者严重并发症的预测：来自 FINITE 研究前瞻性队列患者的临床稳定发热性中性粒细胞减少症指数的验证。

J Clin Oncol. 2015 Feb 10;33(5):465-71. doi: 10.1200/JCO.2014.57.2347. Epub 2015 Jan 5.

The MASCC Neutropenia, Infection and Myelosuppression Study Group evaluates recent new concepts for the use of granulocyte colony-stimulating factors for the prevention of febrile neutropenia.MASCC中性粒细胞减少、感染和骨髓抑制研究小组评估了使用粒细胞集落刺激因子预防发热性中性粒细胞减少的最新概念。

Support Care Cancer. 2013 Jun;21(6):1793-5. doi: 10.1007/s00520-013-1776-9. Epub 2013 Mar 24.

[Breast and Endocrine Tumor Supportive Care for Febrile Neutropenia in Chemotherapy - Current Situation and Future Perspective in Breast Cancer Treatment -].

Gan To Kagaku Ryoho. 2017 Dec;44(13):2072.

Potential reduction of hospital stay length with outpatient management of low-risk febrile neutropenia in a regional cancer center.在区域癌症中心中，对低危发热性中性粒细胞减少症进行门诊管理，可能会减少住院时间。

Cancer Rep (Hoboken). 2021 Jun;4(3):e1345. doi: 10.1002/cnr2.1345. Epub 2021 Feb 26.

本文引用的文献

Validation of the Clinical Index of Stable Febrile Neutropenia (CISNE) model in febrile neutropenia patients visiting the emergency department. Can it guide emergency physicians to a reasonable decision on outpatient vs. inpatient treatment?验证临床稳定中性粒细胞减少性发热指数（CISNE）模型在急诊发热中性粒细胞减少症患者中的应用。它能否指导急诊医师做出合理的门诊与住院治疗决策？

PLoS One. 2018 Dec 31;13(12):e0210019. doi: 10.1371/journal.pone.0210019. eCollection 2018.

Clin Transl Oncol. 2019 Jan;21(1):75-86. doi: 10.1007/s12094-018-1983-4. Epub 2018 Nov 23.

Decision Rules in a Guideline: Allow the Science to Speak.指南中的决策规则：让科学发声。

J Clin Oncol. 2018 Sep 4;36(31):JCO2018788430. doi: 10.1200/JCO.2018.78.8430.

Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update Summary.成人恶性肿瘤患者发热伴中性粒细胞减少的门诊管理：美国临床肿瘤学会和美国传染病学会临床实践指南更新摘要

J Oncol Pract. 2018 Apr;14(4):250-255. doi: 10.1200/JOP.18.00016. Epub 2018 Mar 8.

Comparison of the MASCC and CISNE scores for identifying low-risk neutropenic fever patients: analysis of data from three emergency departments of cancer centers in three continents.MASCC 和 CISNE 评分用于识别低危中性粒细胞减少性发热患者的比较：来自三大洲三个癌症中心急诊部的数据分析。

Support Care Cancer. 2018 May;26(5):1465-1470. doi: 10.1007/s00520-017-3985-0. Epub 2017 Nov 22.

The time has come for new models in febrile neutropenia: a practical demonstration of the inadequacy of the MASCC score.发热性中性粒细胞减少症的新模式已经到来：MASCC 评分不足的实际证明。

Clin Transl Oncol. 2017 Sep;19(9):1084-1090. doi: 10.1007/s12094-017-1644-z. Epub 2017 Mar 13.

Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: the EPIPHANY Index.使用决策树模型预测癌症合并肺栓塞患者的严重并发症：EPIPHANY指数

Br J Cancer. 2017 Apr 11;116(8):994-1001. doi: 10.1038/bjc.2017.48. Epub 2017 Mar 7.

A nomogram for predicting complications in patients with solid tumours and seemingly stable febrile neutropenia.用于预测实体瘤且看似稳定的发热性中性粒细胞减少症患者并发症的列线图。

Br J Cancer. 2016 May 24;114(11):1191-8. doi: 10.1038/bjc.2016.118. Epub 2016 May 17.

J Clin Oncol. 2015 Feb 10;33(5):465-71. doi: 10.1200/JCO.2014.57.2347. Epub 2015 Jan 5.

The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients.多国癌症支持治疗协会（MASCC）风险指数评分：用于识别低危发热性中性粒细胞减少症癌症患者的 10 年应用。

Support Care Cancer. 2013 May;21(5):1487-95. doi: 10.1007/s00520-013-1758-y. Epub 2013 Feb 27.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验